[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621750":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":36,"collaborators":10,"id":38,"slug":10,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":10,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":10,"enrollmentInfo":46,"targetDuration":10,"studyType":49,"phases":10,"briefSummary":50,"conditions":51,"keywords":10,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Long-term Follow-up Cohort",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"KeeJeong Bae, Principal Investigator","CONTACT","+82-10-5202-7469","grant903@gmail.com",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":10,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine","RECRUITING","Seoul","Korea","07061","South Korea",{"type":26,"coordinates":27},"Point",[28,29],126.9784,37.566,{"lat":29,"lon":28},[32],{"name":33,"role":14,"phone":34,"phoneExt":10,"email":35},"Eunmi Anh, Clinical Research Coordinator","+82-2-870-3246","eunmiahn@scorlab.kr",{"type":37,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100621750",false,"NCT07374679","Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease","A Single Center, Open Label, Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease","Inclusion Criteria:\n\n* Subjects who received the investigational medicinal product in the Phase 1\u002F2a clinical trial (ASB-IP-001).\n* Subjects who voluntarily agreed to participate in this long-term follow-up study and provided written informed consent.\n\nExclusion Criteria:\n\n* Subjects who cannot be contacted by any means, including telephone, mail, or e-mail, and for whom follow-up assessment is therefore not feasible.\n* Subjects deemed inappropriate for participation in this long-term follow-up study at the investigator's discretion, including:\n\n  * Cases in which participation in the study may pose a significant risk to the subject's health or safety; ② Cases in which long-term follow-up visits or assessments are practically impossible due to cognitive impairment, communication difficulties, or similar conditions; ③ Cases in which continued participation in follow-up is unlikely due to difficulty adhering to the study schedule (e.g., prolonged hospitalization, long-term residence abroad).","ALL","19 Years",{"count":47,"type":48},21,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease",[52],"Rotator Cuff Disease","2026-05-18",{"date":55,"type":56},"2026-05-22","ACTUAL",{"date":58,"type":56},"2026-01-27",{"date":60,"type":48},"2032-01-30",{"name":5,"class":6},1]